Intangible Assets

CHYM shows no evidence in the provided filings or metrics of durable brand, proprietary IP, or regulatory exclusivity that would let it sustain pricing power versus peers.

Negative TTM ROIC and ROCE indicate the business is not converting any presumed intangible advantage into excess returns, which is weaker than peers with proven premium economics.

No 5-year margin or growth history was provided, so there is no support for a persistent customer preference or protected franchise relative to competitors.

Any intangible asset base appears limited or non-differentiating because the current economics do not show durable monetization versus peers.

Switching Costs

The provided data do not show retention, contract lock-in, or workflow dependence that would make customers materially costly to replace versus peers.

Negative ROIC and ROCE suggest customers are not locked into a high-value, high-margin ecosystem that would preserve pricing power over time.

A very low cash conversion cycle does not by itself indicate switching costs, and it is not enough to establish durable customer captivity versus peers.

Compared with peers that typically exhibit recurring revenue or embedded systems, CHYM lacks evidence of meaningful switching friction.

Network Effects

No evidence was provided of user-to-user, data, or ecosystem network effects that would strengthen CHYM’s competitive position versus peers.

The negative capital returns imply the business is not currently compounding scale into a self-reinforcing platform advantage.

Without signs of expanding engagement, multi-sided adoption, or data flywheel benefits, network effects appear absent or immaterial.

Relative to peers with platform dynamics, CHYM does not show structural dependence that would support durable moat strength.

Cost Advantage

The available metrics do not show a cost position strong enough to generate positive excess returns, which argues against a durable cost advantage versus peers.

Negative ROIC and ROCE indicate that any operating efficiency is not translating into superior unit economics or margin resilience.

Asset turnover is respectable, but without positive returns or margin evidence it does not prove a structural cost edge over competitors.

Compared with peers that can sustain lower costs through scale, procurement, or process advantages, CHYM’s current data do not support a durable cost moat.

Efficient Scale

No evidence was provided that CHYM operates in a niche where market size naturally limits efficient competition or protects returns versus peers.

Negative returns suggest the company is not capturing the economics of a protected scale position, even if the market is concentrated.

The data do not indicate that incumbency, capacity constraints, or regulatory barriers are preventing new entry in a way that would preserve margins.

Relative to peers with clear local monopolies or high fixed-cost scale advantages, CHYM does not show efficient-scale protection.

Overall Score

CHYM shows no demonstrated structural moat in the provided data, and negative ROIC/ROCE versus peers points to weak pricing power, limited retention, and no visible durable advantage across the five moat drivers.